Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000–2020

Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000–2020

Background: Given the rarity and heterogeneity of pancreatic neuroendocrine neoplasms (pNEN), treatment algorithms and sequencing are primarily guided by expert opinions with limited evidence. Aim: To investigate overall survival (OS), median progression-free survival (mPFS), and prognostic factors...

Full description

Bibliographic Details
Main Authors: Sofie Skovlund Petersen, Stine Møller, Cecilie Slott, Jesper Krogh, Carsten Palnæs Hansen, Andreas Kjaer, Pernille Holmager, Peter Oturai, Rajendra Singh Garbyal, Seppo W. Langer, Ulrich Knigge, Mikkel Andreassen
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
pancreatic neuroendocrine tumors
treatment efficacy
somatostatin analogue
peptide receptor radionuclide therapy
everolimus
chemotherapy
Online Access:https://www.mdpi.com/2072-6694/16/6/1190

Internet

https://www.mdpi.com/2072-6694/16/6/1190

Similar Items